NUWELLIS, INC. Net Fee Amt
NUWELLIS, INC. (NUWE) had Net Fee Amt of $248.94 as of 2026-08-18, per its S-3 filed 2026-08-18.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-18
- 2026-08-18: Net Fee Amt $248.94.
- 2026-06-05: Net Fee Amt $697.34.
- 2026-05-29: Net Fee Amt $1.38K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-18 | $248.94 S-3 · filed 2026-08-18 |
| 2026-06-05 | $697.34 S-1MEF · filed 2026-06-05 |
| 2026-05-29 | $1.38K S-1/A · filed 2026-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |